- Home
- UCAR vs DRRX Comparison
UCAR vs DRRX Comparison
Compare UCAR & DRRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UCAR
- DRRX
- Stock Information
- Founded
- UCAR 2013
- DRRX 1998
- Country
- UCAR China
- DRRX United States
- Employees
- UCAR N/A
- DRRX N/A
- Industry
- UCAR Retail-Auto Dealers and Gas Stations
- DRRX Biotechnology: Pharmaceutical Preparations
- Sector
- UCAR Consumer Discretionary
- DRRX Health Care
- Exchange
- UCAR Nasdaq
- DRRX Nasdaq
- Market Cap
- UCAR 23.3M
- DRRX 26.3M
- IPO Year
- UCAR 2023
- DRRX 2000
- Fundamental
- Price
- UCAR $2.82
- DRRX $0.80
- Analyst Decision
- UCAR
- DRRX Buy
- Analyst Count
- UCAR 0
- DRRX 2
- Target Price
- UCAR N/A
- DRRX $5.00
- AVG Volume (30 Days)
- UCAR 218.7K
- DRRX 54.3K
- Earning Date
- UCAR 03-26-2025
- DRRX 03-26-2025
- Dividend Yield
- UCAR N/A
- DRRX N/A
- EPS Growth
- UCAR N/A
- DRRX N/A
- EPS
- UCAR N/A
- DRRX N/A
- Revenue
- UCAR $4,273,899.00
- DRRX $8,594,000.00
- Revenue This Year
- UCAR N/A
- DRRX $54.32
- Revenue Next Year
- UCAR N/A
- DRRX N/A
- P/E Ratio
- UCAR N/A
- DRRX N/A
- Revenue Growth
- UCAR 473.55
- DRRX N/A
- 52 Week Low
- UCAR $2.31
- DRRX $0.70
- 52 Week High
- UCAR $9.43
- DRRX $1.88
- Technical
- Relative Strength Index (RSI)
- UCAR 32.94
- DRRX 49.63
- Support Level
- UCAR $2.64
- DRRX $0.73
- Resistance Level
- UCAR $3.35
- DRRX $0.83
- Average True Range (ATR)
- UCAR 0.45
- DRRX 0.05
- MACD
- UCAR 0.07
- DRRX 0.01
- Stochastic Oscillator
- UCAR 34.23
- DRRX 63.57
About UCAR U Power Limited
U Power Ltd is involved in the provision of vehicle sourcing services. It is principally engaged in the provision of new energy vehicles development and sales; battery swapping stations manufactory and sales; battery swapping services and sourcing services. The company as a broker engaged in sales of vehicles between automobile wholesalers and buyers, including small and medium-sized vehicle dealers and individual customers located in lower-tier cities in China.
About DRRX DURECT Corporation
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .